Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7103919 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TDP1SMN1; SMN2 | |
| SCHEMBL7103917 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TDP1SMN1; SMN2 | |
| SCHEMBL1100795 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TDP1SMN1; SMN2 | |
| SCHEMBL11075645 | 0.88 | ALDH1A1 (0.59) | ALDH1A1TDP1SMN1; SMN2 | |
| SCHEMBL11074748 | 0.88 | ALDH1A1 (0.59) | ALDH1A1TDP1SMN1; SMN2 | |
| SCHEMBL24750411 | 0.82 | MEN1 (0.52) | TDP1SMN1; SMN2 | |
| SCHEMBL24750713 | 0.81 | TDP1 (0.44) | ALDH1A1TDP1SMN1; SMN2 | |
| SCHEMBL9670184 | 0.77 | ALDH1A1 (0.50) | ALDH1A1TDP1SMN1; SMN2 | |
| SCHEMBL9027367 | 0.77 | ALDH1A1 (0.50) | ALDH1A1TDP1SMN1; SMN2 | |
| SCHEMBL12539970 | 0.77 | CYP2A6 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1341800-A2 | C-GLUCOSYL ETHER LIPIDS | The Research Foundation Of the City university of New York (US) | 2003-09-10 | — | — | EP | disclosed |
| US-6613748-B2 | C-glycosides having 2-amino groups; anticancer agents | THE RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 2003-09-02 | — | — | US | disclosed |
| US-20020128214-A1 | C-glucosyl ether lipids | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK, THE | 2002-09-12 | — | — | US | disclosed |
| WO-2002060911-A2 | C-GLUCOSYL ETHER LIPIDS | THE RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 2002-08-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020128214-A1 | C-glucosyl ether lipids | UGCG, LIPC, UGGT1 | ALDH1A1 2464/4885TDP1 4603/4885SMN1; SMN2 4645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.